Invesco’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-109,137
| Closed | -$7.87M | – | 3812 |
|
|
2025
Q4 | $7.87M | Sell |
109,137
-79,226
| -42% | -$5.12M | ﹤0.01% | 2009 |
|
|
2025
Q3 | $8.21M | Sell |
188,363
-54,700
| -23% | -$2.21M | ﹤0.01% | 1948 |
|
|
2025
Q2 | $6.9M | Sell |
243,063
-45,076
| -16% | -$1.34M | ﹤0.01% | 2012 |
|
|
2025
Q1 | $8.51M | Buy |
288,139
+193,376
| +204% | +$6.02M | ﹤0.01% | 1872 |
|
|
2024
Q4 | $2.76M | Sell |
94,763
-215,593
| -69% | -$9.01M | ﹤0.01% | 2498 |
|
|
2024
Q3 | $14.3M | Sell |
310,356
-39,999
| -11% | -$1.74M | ﹤0.01% | 1650 |
|
|
2024
Q2 | $14.3M | Sell |
350,355
-22,961
| -6% | -$659K | ﹤0.01% | 1602 |
|
|
2024
Q1 | $9.53M | Buy |
373,316
+245,444
| +192% | +$3.85M | ﹤0.01% | 1843 |
|
|
2023
Q4 | $1.16M | Sell |
127,872
-10,128
| -7% | -$67.7K | ﹤0.01% | 2829 |
|
|
2023
Q3 | $880K | Buy |
138,000
+44,653
| +48% | +$385K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $1.04M | Sell |
93,347
-73,436
| -44% | -$921K | ﹤0.01% | 2875 |
|
|
2023
Q1 | $2.56M | Buy |
166,783
+97,862
| +142% | +$2.15M | ﹤0.01% | 2539 |
|
|
2022
Q4 | $1.53M | Sell |
68,921
-78,655
| -53% | -$1.17M | ﹤0.01% | 2747 |
|
|
2022
Q3 | $2.41M | Buy |
147,576
+112,540
| +321% | +$2.15M | ﹤0.01% | 2561 |
|
|
2022
Q2 | $509K | Buy |
35,036
+4,799
| +16% | +$71.4K | ﹤0.01% | 3317 |
|
|
2022
Q1 | $558K | Buy |
30,237
+15,442
| +104% | +$262K | ﹤0.01% | 3335 |
|
|
2021
Q4 | $351K | Buy |
14,795
+533
| +4% | +$12.7K | ﹤0.01% | 3545 |
|
|
2021
Q3 | $352K | Buy |
14,262
+2,966
| +26% | +$64.5K | ﹤0.01% | 3587 |
|
|
2021
Q2 | $279K | Buy |
+11,296
| New | +$263K | ﹤0.01% | 3658 |
|
Other funds holding RNAM
Invesco's RNAM Position: Q1 2026 in Review
Invesco sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 109,137 shares — an estimated $7.87M sold.
Invesco first reported a position in RNAM in Q2 2021 and held it in 19 quarters. The position peaked at $14.3M in Q2 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Invesco reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Invesco sold 109,137 Avidity Biosciences shares in Q1 2026, an estimated $7.87M.
- Invesco first reported a position in Avidity Biosciences in Q2 2021 and held it in 19 quarters.
- Invesco's Avidity Biosciences position peaked at $14.3M in Q2 2024.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.